Cite
Prevalence of pathogenic germline variants in the circulating tumor DNA testing.
MLA
Yamamoto, Yoshihiro, et al. “Prevalence of Pathogenic Germline Variants in the Circulating Tumor DNA Testing.” International Journal of Clinical Oncology, vol. 27, no. 10, Oct. 2022, pp. 1554–61. EBSCOhost, https://doi.org/10.1007/s10147-022-02220-x.
APA
Yamamoto, Y., Fukuyama, K., Kanai, M., Kondo, T., Yoshioka, M., Kou, T., Quy, P. N., Kimura-Tsuchiya, R., Yamada, T., Matsumoto, S., Kosugi, S., & Muto, M. (2022). Prevalence of pathogenic germline variants in the circulating tumor DNA testing. International Journal of Clinical Oncology, 27(10), 1554–1561. https://doi.org/10.1007/s10147-022-02220-x
Chicago
Yamamoto, Yoshihiro, Keita Fukuyama, Masashi Kanai, Tomohiro Kondo, Masahiro Yoshioka, Tadayuki Kou, Pham Nguyen Quy, et al. 2022. “Prevalence of Pathogenic Germline Variants in the Circulating Tumor DNA Testing.” International Journal of Clinical Oncology 27 (10): 1554–61. doi:10.1007/s10147-022-02220-x.